SUMMARY Mortality from cystic fibrosis throughout childhood is more than twice as high in England and Wales than it is in the State of Victoria, Australia. Possible reasons for this difference are reviewed.
While there has been a notable improvement in survival from cystic fibrosis during the last 20 years, what has caused this change is far from certain. In the hope of identifying some of the factors, the mortality from cystic fibrosis has been compared in England and Wales and in Victoria, Australia. The incidence of the disease is similar in the two countries, but there are substantial differences in the approach to its management. In Victoria, 90% of children and adolescents are managed in the one clinic. In England and Wales most children are looked after by their local paediatrician and only a small number attend specialist clinics in referral centres.
Material and methods
There has been a long term epidemiological study of cystic fibrosis in the state of Victoria since 1955.1 2 An attempt has been made to identify every diagnosed patient and to record date of birth, mode of presentation, date of diagnosis, and date of death. On the basis of this information, the incidence has been calculated at 1/2556 live births and has not changed appreciably over a 24 year period. There are a number of factors that may explain the difference. As most deaths from cystic fibrosis are due to respiratory infection, differences in climate and socioeconomic conditions in the two communities may lead to more respiratory infections in England and Wales. To test this hypothesis, the age specific death rates from respiratory infections and sudden infant death syndrome from ages of 1 month to 1 year and 1 to 4 years inclusive were calculated for the two communities. There has been a recent fall in the number of deaths from respiratory infection in both communities and an increase in the number of sudden infant deaths that almost certainly reflects changing terminology. Deaths from these two causes were therefore combined. Mortality rates from age 1 month to 1 year and 1 to 4 years were 1-9 and 2-0/1000 live births in Victoria and in England and Wales respectively. These figures do not support the hypothesis that the difference in mortality from cystic fibrosis in the two communities results simply from a different incidence of serious respiratory infection. The rate in Victoria is lower in the 1 to 4 year age group than in England and Wales (0.054 and 0-087/1000 respectively) but the numbers were small (68 deaths in Victoria over the full 5 year period) because death from respiratory infection is rare after the first year of life.
Climatic factors may be important, apart from affecting the incidence of respiratory infections: the opportunity for children to play outdoors is greater in Victoria than in England and Wales. The survival of patients with cystic fibrosis in Victoria,7 is however, very similar to that reported from the Hospital for Sick Children, Toronto8 and Cleveland, United States of America;9 two cities with severe winters that restrict outdoor activities for many months of the year.
There is a major difference between England and Wales and Victoria in the form of care provided for children with cystic fibrosis. It has been claimed in North America that management in a specialist Case 4. Pancuronium bromide was started at 3 hours and continued until 27 hours of age in one girl. Initially she had a full range of joint movements. Seizures were treated with phenobarbitone, which was started on day 2. On day 8 she was noted to have limited extension of both knees and restricted abduction of both hips. Intensive passive stretching exercises were instituted but at 4 months of age full extension in the right knee was still limited by 20 degrees.
